{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:42:23Z","timestamp":1794346943811,"version":"4.9.0"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF23OC0081873"],"award-info":[{"award-number":["NNF23OC0081873"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007435","name":"\u00c5ke Wiberg Stiftelse","doi-asserted-by":"publisher","award":["M24-0251"],"award-info":[{"award-number":["M24-0251"]}],"id":[{"id":"10.13039\/100007435","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002345","name":"Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010823","name":"Tore Nilson Foundation for Medical Research","doi-asserted-by":"publisher","award":["2023-079"],"award-info":[{"award-number":["2023-079"]}],"id":[{"id":"10.13039\/100010823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Brain Foundation","doi-asserted-by":"publisher","award":["FO2023-0292"],"award-info":[{"award-number":["FO2023-0292"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007051","name":"Uppsala Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine Reviews"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.smrv.2025.102069","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T19:05:47Z","timestamp":1738955147000},"page":"102069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The impact of pharmacotherapy for premenstrual dysphoric disorder on sleep"],"prefix":"10.1016","volume":"80","author":[{"given":"Elisa M.S.","family":"Meth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana A.","family":"N\u00f4ga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Dubol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Sundstr\u00f6m-Poromaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8911-4068","authenticated-orcid":false,"given":"Christian","family":"Benedict","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smrv.2025.102069_bib1","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/jog.15484","article-title":"Premenstrual disorders: premenstrual syndrome and premenstrual dysphoric disorder","volume":"49","author":"Takeda","year":"2023","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.smrv.2025.102069_bib2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.mcna.2019.02.007","article-title":"Premenstrual dysphoric disorder","volume":"103","author":"Lanza di Scalea","year":"2019","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.smrv.2025.102069_bib3","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jad.2024.01.066","article-title":"The prevalence of premenstrual dysphoric disorder: systematic review and meta-analysis","volume":"349","author":"Reilly","year":"2024","journal-title":"J Affect Disord"},{"key":"10.1016\/j.smrv.2025.102069_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-0327(01)00458-X","article-title":"Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles","volume":"70","author":"Cohen","year":"2002","journal-title":"J Affect Disord"},{"key":"10.1016\/j.smrv.2025.102069_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1034\/j.1600-0412.2000.079005405.x","article-title":"Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives","volume":"79","author":"Sveind\u00f3ttir","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.smrv.2025.102069_bib6","first-page":"1","article-title":"The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS\/PMDD)","volume":"28","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.smrv.2025.102069_bib7","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1089\/jwh.2021.0185","article-title":"Suicidal risk in women with premenstrual syndrome and premenstrual dysphoric disorder: a systematic review and meta-analysis","volume":"30","author":"Prasad","year":"2021","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.smrv.2025.102069_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1176\/appi.ajp.2012.11081302","article-title":"Premenstrual dysphoric disorder: evidence for a new category for DSM-5","volume":"169","author":"Epperson","year":"2012","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.smrv.2025.102069_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2020.100856","article-title":"Progesterone - friend or foe?","volume":"59","author":"Sundstr\u00f6m-Poromaa","year":"2020","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.smrv.2025.102069_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1258\/mi.2012.012014","article-title":"Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder","volume":"18","author":"Rapkin","year":"2012","journal-title":"Menopause Int"},{"key":"10.1016\/j.smrv.2025.102069_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105168","article-title":"Towards understanding the biology of premenstrual dysphoric disorder: from genes to GABA","volume":"149","author":"Hantsoo","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.smrv.2025.102069_bib12","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/da.22673","article-title":"Treatment of premenstrual dysphoria with continuous versus intermittent dosing of oral contraceptives: results of a three-arm randomized controlled trial","volume":"34","author":"Eisenlohr-Moul","year":"2017","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.smrv.2025.102069_bib13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.psyneuen.2004.07.003","article-title":"Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone","volume":"30","author":"Andr\u00e9en","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.smrv.2025.102069_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1176\/appi.ajp.2020.20030286","article-title":"Ulipristal acetate for treatment of premenstrual dysphoric disorder: a proof-of-concept randomized controlled trial","volume":"178","author":"Comasco","year":"2021","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.smrv.2025.102069_bib15","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.biopsych.2022.12.023","article-title":"Increase in serotonin transporter binding in patients with premenstrual dysphoric disorder across the menstrual cycle: a case-control longitudinal neuroreceptor ligand positron emission tomography imaging study","volume":"93","author":"Sacher","year":"2023","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.smrv.2025.102069_bib16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1476-5381.1973.tb08246.x","article-title":"The oestrous cycle and monoamine oxidase activity","volume":"48","author":"Holzbauer","year":"1973","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.smrv.2025.102069_bib17","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1176\/appi.ajp.160.8.1522","article-title":"Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women","volume":"160","author":"Kugaya","year":"2003","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.smrv.2025.102069_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00213-001-0959-0","article-title":"Ovarian steroid regulation of monoamine oxidase-A and -B mRNAs in the macaque dorsal raphe and hypothalamic nuclei","volume":"160","author":"Gundlah","year":"2002","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.smrv.2025.102069_bib19","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1038\/s41380-024-02566-w","article-title":"Neuroactive steroid hormone trajectories across the menstrual cycle in premenstrual dysphoric disorder (PMDD): the PHASE study","volume":"29","author":"Hamidovic","year":"2024","journal-title":"Mol Psychiatr"},{"issue":"11","key":"10.1016\/j.smrv.2025.102069_bib20","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1038\/s41380-021-01144-8","article-title":"Altered estradiol-dependent cellular Ca2+ homeostasis and endoplasmic reticulum stress response in Premenstrual Dysphoric Disorder","volume":"26","author":"Li","year":"2021","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.smrv.2025.102069_bib21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrn1703","article-title":"Neurosteroids: endogenous regulators of the GABA(A) receptor","volume":"6","author":"Belelli","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.smrv.2025.102069_bib22","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/npp.2015.246","article-title":"5\u03b1-Reductase inhibition prevents the luteal phase increase in plasma allopregnanolone levels and mitigates symptoms in women with premenstrual dysphoric disorder","volume":"41","author":"Martinez","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.smrv.2025.102069_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2021.105426","article-title":"A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorder","volume":"133","author":"B\u00e4ckstr\u00f6m","year":"2021","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.smrv.2025.102069_bib24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.biopsych.2013.02.019","article-title":"How might circadian rhythms control mood? Let me count the ways","volume":"74","author":"McClung","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.smrv.2025.102069_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/npp.2012.140","article-title":"Electrophysiological effects of repeated administration of agomelatine on the dopamine, norepinephrine, and serotonin systems in the rat brain","volume":"38","author":"Chenu","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.smrv.2025.102069_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113724","article-title":"Antidepressant actions of melatonin and melatonin receptor agonist: focus on pathophysiology and treatment","volume":"420","author":"Wang","year":"2022","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.smrv.2025.102069_bib27","article-title":"Sleep, hormones, and circadian rhythms throughout the menstrual cycle in healthy women and women with premenstrual dysphoric disorder","volume":"2010","author":"Shechter","year":"2010","journal-title":"Internet J Endocrinol"},{"key":"10.1016\/j.smrv.2025.102069_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051929","article-title":"Pilot investigation of the circadian plasma melatonin rhythm across the menstrual cycle in a small group of women with premenstrual dysphoric disorder","volume":"7","author":"Shechter","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.smrv.2025.102069_bib29","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archpsyc.1990.01810240059010","article-title":"Altered waveform of plasma nocturnal melatonin secretion in premenstrual depression","volume":"47","author":"Parry","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.smrv.2025.102069_bib30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.psychres.2007.11.017","article-title":"Late, but not early, wake therapy reduces morning plasma melatonin: relationship to mood in Premenstrual Dysphoric Disorder","volume":"161","author":"Parry","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.smrv.2025.102069_bib31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/074873049701200506","article-title":"Blunted phase-shift responses to morning bright light in premenstrual dysphoric disorder","volume":"12","author":"Parry","year":"1997","journal-title":"J Biol Rhythm"},{"key":"10.1016\/j.smrv.2025.102069_bib32","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3109\/07420528.2010.503331","article-title":"Increased sensitivity to light-induced melatonin suppression in premenstrual dysphoric disorder","volume":"27","author":"Parry","year":"2010","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.smrv.2025.102069_bib33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s12905-024-03395-3","article-title":"Biological rhythms in premenstrual syndrome and premenstrual dysphoric disorder: a systematic review","volume":"24","author":"Nexha","year":"2024","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.smrv.2025.102069_bib34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/10673220902891836","article-title":"Update on research and treatment of premenstrual dysphoric disorder","volume":"17","author":"Cunningham","year":"2009","journal-title":"Harv Rev Psychiatr"},{"key":"10.1016\/j.smrv.2025.102069_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/14656566.2022.2114345","article-title":"The pharmacotherapeutic management of premenstrual dysphoric disorder","volume":"24","author":"Ciccone","year":"2023","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.smrv.2025.102069_bib36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/14656566.9.3.429","article-title":"The pharmacologic management of premenstrual dysphoric disorder","volume":"9","author":"Rapkin","year":"2008","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.smrv.2025.102069_bib37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s40263-023-01004-9","article-title":"New pharmacological approaches to the management of premenstrual dysphoric disorder","volume":"37","author":"Sundstr\u00f6m-Poromaa","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/j.smrv.2025.102069_bib38","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2165\/00003495-200565070-00003","article-title":"Antidepressants and sleep: a qualitative review of the literature","volume":"65","author":"Wilson","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.smrv.2025.102069_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11920-017-0816-4","article-title":"Effects of antidepressants on sleep","volume":"19","author":"Wichniak","year":"2017","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.smrv.2025.102069_bib40","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ijo.2013.114","article-title":"Sleep restriction increases the neuronal response to unhealthy food in normal-weight individuals","volume":"38","author":"St-Onge","year":"2014","journal-title":"Int J Obes"},{"key":"10.1016\/j.smrv.2025.102069_bib41","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3945\/ajcn.111.027383","article-title":"Sleep restriction leads to increased activation of brain regions sensitive to food stimuli","volume":"95","author":"St-Onge","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.smrv.2025.102069_bib42","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3945\/ajcn.111.013904","article-title":"Short sleep duration increases energy intakes but does not change energy expenditure in normal-weight individuals","volume":"94","author":"St-Onge","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.smrv.2025.102069_bib43","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.neuroimage.2013.01.018","article-title":"Daytime sleepiness affects prefrontal regulation of food intake","volume":"71","author":"Killgore","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.smrv.2025.102069_bib44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41562-019-0754-8","article-title":"Overanxious and underslept","volume":"4","author":"Ben Simon","year":"2020","journal-title":"Nat Hum Behav"},{"key":"10.1016\/j.smrv.2025.102069_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.paid.2023.112322","article-title":"Associations between sleep quality and irritability: testing the mediating role of emotion regulation","volume":"213","author":"Whiting","year":"2023","journal-title":"Pers Indiv Differ"},{"key":"10.1016\/j.smrv.2025.102069_bib46","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1038\/s41467-018-05377-0","article-title":"Sleep loss causes social withdrawal and loneliness","volume":"9","author":"Ben Simon","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.smrv.2025.102069_bib47","doi-asserted-by":"crossref","first-page":"21209","DOI":"10.1073\/pnas.2004535117","article-title":"Sleepiness, sleep duration, and human social activity: an investigation into bidirectionality using longitudinal time-use data","volume":"117","author":"Holding","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.smrv.2025.102069_bib48","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.smrv.2011.03.008","article-title":"Insomnia and daytime cognitive performance: a meta-analysis","volume":"16","author":"Fortier-Brochu","year":"2012","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2025.102069_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.sleep.2014.07.028","article-title":"Daytime sleepiness associated with poor sustained attention in middle and late adulthood","volume":"16","author":"Yun","year":"2015","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102069_bib50","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1523\/JNEUROSCI.2408-18.2018","article-title":"The pain of sleep loss: a brain characterization in humans","volume":"39","author":"Krause","year":"2019","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2025.102069_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2023.101835","article-title":"The impact of sleep disturbance on pain perception: a systematic review examining the moderating effect of sex and age","volume":"71","author":"Rouhi","year":"2023","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2025.102069_bib52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0165-0327(98)00221-3","article-title":"Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects","volume":"51","author":"Stahl","year":"1998","journal-title":"J Affect Disord"},{"key":"10.1016\/j.smrv.2025.102069_bib53","doi-asserted-by":"crossref","first-page":"12599","DOI":"10.1073\/pnas.93.22.12599","article-title":"Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography","volume":"93","author":"Uzunov","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.smrv.2025.102069_bib54","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.pbb.2006.07.032","article-title":"Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: implications for therapeutic actions","volume":"84","author":"Marx","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.smrv.2025.102069_bib55","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.brainres.2004.07.018","article-title":"Essentiality of central GABAergic neuroactive steroid allopregnanolone for anticonvulsant action of fluoxetine against pentylenetetrazole-induced seizures in mice","volume":"1023","author":"Ugale","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.smrv.2025.102069_bib56","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1017\/S1461145710001471","article-title":"SSRI augmentation of antipsychotic alters expression of GABA(A) receptor and related genes in PMC of schizophrenia patients","volume":"14","author":"Silver","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.smrv.2025.102069_bib57","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1124\/jpet.102.044834","article-title":"Fluoxetine increases GABA(A) receptor activity through a novel modulatory site","volume":"304","author":"Robinson","year":"2003","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.smrv.2025.102069_bib58","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2165\/00019053-200523050-00003","article-title":"Effects of antidepressants on quality of life in women with premenstrual dysphoric disorder","volume":"23","author":"Freeman","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.smrv.2025.102069_bib59","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2165\/00003495-200262130-00004","article-title":"Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?","volume":"62","author":"Pearlstein","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.smrv.2025.102069_bib60","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1139\/jpn.0828","article-title":"Premenstrual dysphoric disorder: burden of illness and treatment update","volume":"33","author":"Pearlstein","year":"2008","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.smrv.2025.102069_bib61","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4088\/JCP.v58n0905","article-title":"Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome","volume":"58","author":"Halbreich","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.smrv.2025.102069_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2022.101670","article-title":"Sleep and affect: a conceptual review","volume":"65","author":"Ten Brink","year":"2022","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2025.102069_bib63","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/PRA.0000000000000578","article-title":"Selective serotonin reuptake inhibitors: how long is long enough?","volume":"27","author":"Thom","year":"2021","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.smrv.2025.102069_bib64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/da.1043","article-title":"Depression, sleep physiology, and antidepressant drugs","volume":"14","author":"Winokur","year":"2001","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.smrv.2025.102069_bib65","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1002\/hup.386","article-title":"Onset of action of antidepressants: results of different analyses","volume":"17","author":"Thompson","year":"2002","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.smrv.2025.102069_bib66","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0269881108089871","article-title":"Effect of antidepressants on melatonin metabolite in depressed patients","volume":"23","author":"Carvalho","year":"2009","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.smrv.2025.102069_bib67","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.smrv.2004.05.002","article-title":"Melatonin as a chronobiotic","volume":"9","author":"Arendt","year":"2005","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2025.102069_bib68","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1007\/s00213-018-5019-0","article-title":"The SSRI citalopram increases the sensitivity of the human circadian system to light in an acute dose","volume":"235","author":"McGlashan","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.smrv.2025.102069_bib69","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1152\/physrev.00013.2010","article-title":"Intrinsically photosensitive retinal ganglion cells","volume":"90","author":"Do","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.smrv.2025.102069_bib70","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1523\/JNEUROSCI.01-12-01414.1981","article-title":"Effects of damage to the suprachiasmatic area of the anterior hypothalamus on the daily melatonin and cortisol rhythms in the rhesus monkey","volume":"1","author":"Reppert","year":"1981","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2025.102069_bib71","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.neuroscience.2004.12.012","article-title":"Environmental light and suprachiasmatic nucleus interact in the regulation of body temperature","volume":"132","author":"Scheer","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.smrv.2025.102069_bib72","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1017\/S1092852900019726","article-title":"SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants","volume":"10","author":"Stahl","year":"2005","journal-title":"CNS Spectr"},{"key":"10.1016\/j.smrv.2025.102069_bib73","first-page":"737","article-title":"Venlafaxine in the treatment of premenstrual dysphoric disorder","volume":"98","author":"Freeman","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.smrv.2025.102069_bib74","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1517\/14656566.9.4.517","article-title":"Duloxetine for premenstrual dysphoric disorder: a pilot study","volume":"9","author":"Mazza","year":"2008","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.smrv.2025.102069_bib75","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1017\/S1461145709000066","article-title":"Duloxetine treatment for women with premenstrual dysphoric disorder: a single-blind trial","volume":"12","author":"Ramos","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.smrv.2025.102069_bib76","first-page":"637","article-title":"A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression","volume":"32","author":"Luthringer","year":"1996","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.smrv.2025.102069_bib77","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/WNR.0000000000000379","article-title":"Distinct effects of the serotonin-noradrenaline reuptake inhibitors milnacipran and venlafaxine on rat pineal monoamines","volume":"26","author":"Muneoka","year":"2015","journal-title":"Neuroreport"},{"key":"10.1016\/j.smrv.2025.102069_bib78","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/026988119801200407","article-title":"Effect of venlafaxine on pineal melatonin and noradrenaline in the male rat","volume":"12","author":"Franklin","year":"1998","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.smrv.2025.102069_bib79","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s002130051004","article-title":"The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET","volume":"144","author":"Meyer","year":"1999","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.smrv.2025.102069_bib80","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/026988110101500110","article-title":"Intermittent, luteal phase nefazodone treatment of premenstrual dysphoric disorder","volume":"15","author":"Kodesh","year":"2001","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.smrv.2025.102069_bib81","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.clinbiochem.2016.06.014","article-title":"Melatonin and pro-hypnotic effectiveness of the antidepressant Trazodone: a preliminary evaluation in insomniac mood-disorder patients","volume":"49","author":"Giannaccini","year":"2016","journal-title":"Clin Biochem"},{"key":"10.1016\/j.smrv.2025.102069_bib82","doi-asserted-by":"crossref","first-page":"285","DOI":"10.7326\/0003-4819-130-4-199902160-00013","article-title":"Nefazodone-induced liver failure: report of three cases","volume":"130","author":"Aranda-Michel","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.smrv.2025.102069_bib83","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjp.0707253","article-title":"Tricyclic antidepressant pharmacology and therapeutic drug interactions updated","volume":"151","author":"Gillman","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.smrv.2025.102069_bib84","first-page":"4","article-title":"Mechanism of action of antidepressant medications","volume":"60","author":"Feighner","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.smrv.2025.102069_bib85","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0447.1992.tb01440.x","article-title":"Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial","volume":"85","author":"Sundblad","year":"1992","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.smrv.2025.102069_bib86","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/npp.1993.52","article-title":"Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial","volume":"9","author":"Sundblad","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.smrv.2025.102069_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpsy.2007.01.746","article-title":"Efficacy of fluoxetine compared to amitriptyline in patients with premenstrual dysphoric disorder","volume":"22","author":"Bardenshteyn","year":"2007","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.smrv.2025.102069_bib88","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0025-6196(25)19144-1","article-title":"Tricyclic antidepressants and histamine H1 receptors","volume":"54","author":"Richelson","year":"1979","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.smrv.2025.102069_bib89","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.smrv.2012.08.001","article-title":"Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications","volume":"17","author":"Krystal","year":"2013","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2025.102069_bib90","doi-asserted-by":"crossref","unstructured":"Follenius M, Spiegel K, Gronfier C, Saini J, Brandenberger G. Clomipramine-induced sleep disturbance does not impair its prolactin-releasing action. J Endocrinol Investig.;17:417-423.","DOI":"10.1007\/BF03347728"},{"key":"10.1016\/j.smrv.2025.102069_bib91","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/BF01975137","article-title":"Antidepressant drugs elevate rat pineal and plasma melatonin","volume":"36","author":"Wirz-Justice","year":"1980","journal-title":"Experientia"},{"key":"10.1016\/j.smrv.2025.102069_bib92","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0028-3908(85)90080-2","article-title":"Serotonin and antidepressant drugs antagonize melatonin-induced behavioural changes after injection into the nucleus accumbens of rats","volume":"24","author":"Gaffori","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.smrv.2025.102069_bib93","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1210\/jcem-68-3-632","article-title":"The effects of intravenous clomipramine on neurohormones in normal subjects","volume":"68","author":"Golden","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.smrv.2025.102069_bib94","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/bmj.325.7371.991","article-title":"Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review","volume":"325","author":"Furukawa","year":"2002","journal-title":"Br Med J"},{"key":"10.1016\/j.smrv.2025.102069_bib95","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00004850-199709000-00004","article-title":"A double-blind six months comparative study of milnacipran and clomipramine in major depressive disorder","volume":"12","author":"Steen","year":"1997","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.smrv.2025.102069_bib96","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJM199305273282108","article-title":"Hormonal contraception","volume":"328","author":"Baird","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.smrv.2025.102069_bib97","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.smrv.2025.102069_bib98","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.contraception.2005.08.021","article-title":"Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation","volume":"72","author":"Pearlstein","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.smrv.2025.102069_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpsycho.2023.08.003","article-title":"Levonorgestrel intrauterine device and depression: a Swedish register-based cohort study","volume":"193","author":"Stenhammar","year":"2023","journal-title":"Int J Psychophysiol"},{"key":"10.1016\/j.smrv.2025.102069_bib100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.psyneuen.2016.11.033","article-title":"Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle-A double-blind, placebo-controlled randomized trial","volume":"76","author":"Lundin","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.smrv.2025.102069_bib101","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/da.22673","article-title":"Treatment of premenstrual dysphoria with continuous versus intermittent dosing of oral contraceptives: results of a three-arm randomized controlled trial","volume":"34","author":"Eisenlohr-Moul","year":"2017","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.smrv.2025.102069_bib102","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.annepidem.2022.07.006","article-title":"The effects of hormonal contraceptive use on sleep patterns in women of reproductive age","volume":"74","author":"Whitney","year":"2022","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.smrv.2025.102069_bib103","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.12983","article-title":"Hormonal contraceptive use and subjective sleep reports in women: an online survey","volume":"29","author":"Bezerra","year":"2020","journal-title":"J Sleep Res"},{"key":"10.1016\/j.smrv.2025.102069_bib104","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00403-015-1600-0","article-title":"A randomized comparative trial of a combined oral contraceptive and azelaic acid to assess their effect on sleep quality in adult female acne patients","volume":"307","author":"Albuquerque","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.smrv.2025.102069_bib105","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/01.gme.0000240633.46300.fa","article-title":"Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life","volume":"13","author":"Soares","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.smrv.2025.102069_bib106","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.brainres.2004.01.089","article-title":"Estradiol enhances light-induced expression of transcription factors in the SCN","volume":"1010","author":"Abizaid","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.smrv.2025.102069_bib107","first-page":"304","article-title":"Effects of estradiol on melatonin and protein synthesis in the rat pineal organ","volume":"5","author":"Cardinali","year":"1974","journal-title":"Horm Res"},{"key":"10.1016\/j.smrv.2025.102069_bib108","doi-asserted-by":"crossref","first-page":"E614","DOI":"10.1210\/jc.2010-2558","article-title":"Progesterone prevents sleep disturbances and modulates GH, TSH, and melatonin secretion in postmenopausal women","volume":"96","author":"Caufriez","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.smrv.2025.102069_bib109","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1177\/0091270008318669","article-title":"The effect of oral contraceptives on the pharmacokinetics of melatonin in healthy subjects with CYP1A2 g.-163C>A polymorphism","volume":"48","author":"Hilli","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.smrv.2025.102069_bib110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF00544361","article-title":"Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives","volume":"28","author":"Abernethy","year":"1985","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.smrv.2025.102069_bib111","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa2204737","article-title":"Acute effects of coffee consumption on health among ambulatory adults","volume":"388","author":"Marcus","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.smrv.2025.102069_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1472-6483(11)60210-1","article-title":"Gonadotrophin-releasing hormone (GnRH) and GnRH agonists: mechanisms of action","volume":"5","author":"Ortmann","year":"2002","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.smrv.2025.102069_bib113","first-page":"303","article-title":"Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study","volume":"33","author":"Freeman","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.smrv.2025.102069_bib114","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1471-0528.2004.00135.x","article-title":"The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: a meta analysis","volume":"111","author":"Wyatt","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.smrv.2025.102069_bib115","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/archinte.166.12.1262","article-title":"Severe hot flashes are associated with chronic insomnia","volume":"166","author":"Ohayon","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.smrv.2025.102069_bib116","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.5665\/sleep.3244","article-title":"A gonadotropin-releasing hormone agonist model demonstrates that nocturnal hot flashes interrupt objective sleep","volume":"36","author":"Joffe","year":"2013","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2025.102069_bib117","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13643-019-1163-9","article-title":"Comparative effectiveness and safety of pharmacological and non-pharmacological interventions for insomnia: an overview of reviews","volume":"8","author":"Rios","year":"2019","journal-title":"Syst Rev"},{"key":"10.1016\/j.smrv.2025.102069_bib118","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","article-title":"Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research","volume":"17","author":"Brandt","year":"2017","journal-title":"Drugs R&D"},{"key":"10.1016\/j.smrv.2025.102069_bib119","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(97)00086-9","article-title":"Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects","volume":"17","author":"Sundstr\u00f6m","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.smrv.2025.102069_bib120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0306-4530(96)00035-2","article-title":"Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study","volume":"22","author":"Sundstr\u00f6m","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.smrv.2025.102069_bib121","doi-asserted-by":"crossref","first-page":"43","DOI":"10.64719\/pb.4483","article-title":"A comprehensive review of lemborexant to treat insomnia","volume":"54","author":"Fuller","year":"2024","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.smrv.2025.102069_bib122","article-title":"Effects of exogenous melatonin on sleep and circadian rhythms in women with premenstrual dysphoric disorder","volume":"44","author":"Moderie","year":"2021","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2025.102069_bib123","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/ror.0.0040067","article-title":"Inhibitory effect of melatonin on GnRH-induced LH release","volume":"4","author":"Vanecek","year":"1999","journal-title":"Rev Reprod"},{"key":"10.1016\/j.smrv.2025.102069_bib124","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.smrv.2007.06.003","article-title":"Evolving applications of light therapy","volume":"11","author":"Terman","year":"2007","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2025.102069_bib125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00737-022-01283-z","article-title":"A 1-week sleep and light intervention improves mood in premenstrual dysphoric disorder in association with shifting melatonin offset time earlier","volume":"26","author":"Parry","year":"2023","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.smrv.2025.102069_bib126","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-1781(99)00043-8","article-title":"A controlled study of light therapy in women with late luteal phase dysphoric disorder","volume":"86","author":"Lam","year":"1999","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.smrv.2025.102069_bib127","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00737-009-0052-y","article-title":"Cognitive-behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review","volume":"12","author":"Lustyk","year":"2009","journal-title":"Arch Womens Ment Health"}],"container-title":["Sleep Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108707922500022X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108707922500022X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:41:01Z","timestamp":1790376061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108707922500022X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":127,"alternative-id":["S108707922500022X"],"URL":"https:\/\/doi.org\/10.1016\/j.smrv.2025.102069","relation":{},"ISSN":["1087-0792"],"issn-type":[{"value":"1087-0792","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of pharmacotherapy for premenstrual dysphoric disorder on sleep","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smrv.2025.102069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102069"}}